Dr Reddys Laboratories announced the launch of Doxercalciferol Injection, 4 mcg/2 ml (2 mcg/ml) Multiple-Dose Vials, the therapeutic generic equivalent of Hectorol (doxercalciferol) Injection 4 mcg/2 ml (2 mcg/ml) MultipleDose Vials, approved by the U.S. Food and Drug Administration (USFDA).
The Hectorol Injection 4 mcg/2 ml (2 mcg/ml) Single-Dose Vials and Multiple-Dose Vials brand and generics had U.S. sales of approximately $138 million MAT for the most recent twelve months ending in September 2019 according to IQVIA Health.
Hectorol is a trademark of Sanofi-Aventis US LLC.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
